Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06795152 · ClinicalTrials.gov registry record
Rare Glycogen Storage Diseases Natural History Study
A clinical trial of Glycogen Storage Disease and GSD Type 0A, sponsored by Duke University.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06795152 is a study of Glycogen Storage Disease and GSD Type 0A that is actively recruiting participants, run by Duke University. The registered enrollment target is 200 participants, above the 44-participant average among 3 other Glycogen Storage Disease trials with a reported enrollment target (355% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06795152, a study of Glycogen Storage Disease and GSD Type 0A, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect and study key medical data about several ultra-rare GSDs (Glycogen Storage Diseases) including, but not limited to, GSD types 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome and Danon disease.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-12-23 |
| Est. Completion | 2034-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06795152
The ClinicalTrials.gov registry entry for NCT06795152 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 44-participant average among 3 other Glycogen Storage Disease trials with a reported enrollment target (355% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Glycogen Storage Disease appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT06795152 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06795152 about?
NCT06795152 is a clinical study titled "Rare Glycogen Storage Diseases Natural History Study". The purpose of this study is to collect and study key medical data about several ultra-rare GSDs (Glycogen Storage Diseases) including, but not limited to, GSD types 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome and Danon disease.
What is the current status of trial NCT06795152?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-12-23. Estimated completion is 2034-12.
What conditions does trial NCT06795152 study?
This clinical trial studies the following conditions: Glycogen Storage Disease, GSD Type 0A, GSD Type 0B, GSD VII, Tarui Disease.
What interventions are being tested in trial NCT06795152?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT06795152?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06795152 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glycogen Storage Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.